
Company Number
13174032
Next Accounts
Dec 2025
Shareholders
-
Group Structure
View All
Industry
Other social work activities without accommodation n.e.c.
Registered Address
28 jamestown road, camden, london, NW1 7BY
Website
drmartensplc.comPomanda estimates the enterprise value of DR. MARTENS FOUNDATION at £346k based on a Turnover of £935k and 0.37x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of DR. MARTENS FOUNDATION at £0 based on an EBITDA of £-1.2m and a 4.15x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of DR. MARTENS FOUNDATION at £492.5k based on Net Assets of £251k and 1.96x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dr. Martens Foundation is a live company located in london, NW1 7BY with a Companies House number of 13174032. It operates in the other social work activities without accommodation n.e.c. sector, SIC Code 88990. Founded in February 2021, it's largest shareholder is unknown. Dr. Martens Foundation is a startup, small sized company, Pomanda has estimated its turnover at £935k with unknown growth in recent years.
Pomanda's financial health check has awarded Dr. Martens Foundation a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
5 Weak
Size
annual sales of £935k, make it larger than the average company (£486.8k)
£935k - Dr. Martens Foundation
£486.8k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Dr. Martens Foundation
- - Industry AVG
Production
with a gross margin of 67.8%, this company has a comparable cost of product (67.8%)
67.8% - Dr. Martens Foundation
67.8% - Industry AVG
Profitability
an operating margin of -124.7% make it less profitable than the average company (3.5%)
-124.7% - Dr. Martens Foundation
3.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (14)
1 - Dr. Martens Foundation
14 - Industry AVG
Pay Structure
on an average salary of £71k, the company has a higher pay structure (£25.1k)
£71k - Dr. Martens Foundation
£25.1k - Industry AVG
Efficiency
resulting in sales per employee of £935k, this is more efficient (£39.5k)
£935k - Dr. Martens Foundation
£39.5k - Industry AVG
Debtor Days
it gets paid by customers after 1 days, this is earlier than average (14 days)
1 days - Dr. Martens Foundation
14 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Dr. Martens Foundation
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Dr. Martens Foundation
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 94 weeks, this is less cash available to meet short term requirements (236 weeks)
94 weeks - Dr. Martens Foundation
236 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 54.5%, this is a higher level of debt than the average (13%)
54.5% - Dr. Martens Foundation
13% - Industry AVG
Dr. Martens Foundation's latest turnover from March 2024 is £935 thousand and the company has net assets of £251 thousand. According to their latest financial statements, Dr. Martens Foundation has 1 employee and maintains cash reserves of £549 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | |
---|---|---|---|
Turnover | 935,000 | 181,000 | 3,320,000 |
Other Income Or Grants | |||
Cost Of Sales | |||
Gross Profit | |||
Admin Expenses | |||
Operating Profit | |||
Interest Payable | |||
Interest Receivable | |||
Pre-Tax Profit | -1,108,000 | -973,000 | 2,460,000 |
Tax | |||
Profit After Tax | -1,108,000 | -973,000 | 2,460,000 |
Dividends Paid | |||
Retained Profit | -1,108,000 | -973,000 | 2,460,000 |
Employee Costs | 71,000 | 63,000 | 9,000 |
Number Of Employees | 1 | 1 | |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | |
---|---|---|---|
Tangible Assets | |||
Intangible Assets | |||
Investments & Other | |||
Debtors (Due After 1 year) | |||
Total Fixed Assets | |||
Stock & work in progress | |||
Trade Debtors | 3,000 | 201,000 | |
Group Debtors | |||
Misc Debtors | |||
Cash | 549,000 | 1,668,000 | 2,804,000 |
misc current assets | |||
total current assets | 552,000 | 1,668,000 | 3,005,000 |
total assets | 552,000 | 1,668,000 | 3,005,000 |
Bank overdraft | |||
Bank loan | |||
Trade Creditors | 536,000 | ||
Group/Directors Accounts | |||
other short term finances | |||
hp & lease commitments | |||
other current liabilities | 301,000 | 309,000 | 9,000 |
total current liabilities | 301,000 | 309,000 | 545,000 |
loans | |||
hp & lease commitments | |||
Accruals and Deferred Income | |||
other liabilities | |||
provisions | |||
total long term liabilities | |||
total liabilities | 301,000 | 309,000 | 545,000 |
net assets | 251,000 | 1,359,000 | 2,460,000 |
total shareholders funds | 251,000 | 1,359,000 | 2,460,000 |
Mar 2024 | Mar 2023 | Mar 2022 | |
---|---|---|---|
Operating Activities | |||
Operating Profit | |||
Depreciation | |||
Amortisation | |||
Tax | |||
Stock | |||
Debtors | 3,000 | -201,000 | 201,000 |
Creditors | -536,000 | 536,000 | |
Accruals and Deferred Income | -8,000 | 300,000 | 9,000 |
Deferred Taxes & Provisions | |||
Cash flow from operations | |||
Investing Activities | |||
capital expenditure | |||
Change in Investments | |||
cash flow from investments | |||
Financing Activities | |||
Bank loans | |||
Group/Directors Accounts | |||
Other Short Term Loans | |||
Long term loans | |||
Hire Purchase and Lease Commitments | |||
other long term liabilities | |||
share issue | |||
interest | |||
cash flow from financing | -128,000 | ||
cash and cash equivalents | |||
cash | -1,119,000 | -1,136,000 | 2,804,000 |
overdraft | |||
change in cash | -1,119,000 | -1,136,000 | 2,804,000 |
Perform a competitor analysis for dr. martens foundation by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in NW1 area or any other competitors across 12 key performance metrics.
DR. MARTENS FOUNDATION group structure
Dr. Martens Foundation has no subsidiary companies.
Ultimate parent company
DR. MARTENS FOUNDATION
13174032
Dr. Martens Foundation currently has 6 directors. The longest serving directors include Ms Emily Reichwald (Feb 2021) and Mr Paul Armstrong (Feb 2021).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Emily Reichwald | 49 years | Feb 2021 | - | Director | |
Mr Paul Armstrong | United Kingdom | 51 years | Feb 2021 | - | Director |
Ms Tuze Mekik Arguedas Schwank | United Kingdom | 48 years | Mar 2021 | - | Director |
Ms Pamela Shores | United Kingdom | 53 years | Apr 2021 | - | Director |
Ms Greet Raeymaekers | United Kingdom | 43 years | Sep 2024 | - | Director |
Mr Dennis Sparks, Jr. | United Kingdom | 52 years | Jan 2025 | - | Director |
P&L
March 2024turnover
935k
+417%
operating profit
-1.2m
0%
gross margin
67.9%
+0.2%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
251k
-0.82%
total assets
552k
-0.67%
cash
549k
-0.67%
net assets
Total assets minus all liabilities
Similar Companies
company number
13174032
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
88990 - Other social work activities without accommodation n.e.c.
incorporation date
February 2021
age
4
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2024
previous names
ampgoodcauses limited (April 2021)
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
28 jamestown road, camden, london, NW1 7BY
Bank
HSBC BANK PLC
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to dr. martens foundation.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DR. MARTENS FOUNDATION. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|